|
|
||||||||
1 Department of Biochemistry, Tokyo University of Pharmacy and Life Science, Hachioji, Tokyo 192-0392; and 2 Laboratory of Reproductive Endocrinology, National Institute of Animal Industry, Tsukuba, Ibaraki 305-0901, Japan
| |
ABSTRACT |
|---|
|
|
|---|
Prostaglandins (PGs) cause uterine
contraction to initiate labor at term. We investigated the effect of
progesterone and 17
-estradiol on the production of PGE2
in rabbit uterine cervical fibroblasts. When the cervical
fibroblasts were treated with interleukin-1
(IL-1
), the level of
PGE2 was augmented in a time- and dose-dependent manner.
The IL-1
-augmented PGE2 level was almost completely
suppressed by progesterone and 17
-estradiol at the physiological
concentration (0.01 µM), whereas a slight decrease in the basal level
of PGE2 was observed in the cervical fibroblasts treated
with both hormones at a pharmacological concentration (1 µM). In
addition, the level of PGE2 augmented by IL-1
was due to
the increase of cyclooxygenase (COX) activity, which was inhibited by
progesterone and 17
-estradiol as well as by indomethacin and a
specific COX-2 inhibitor, NS-398, but not by the well-known COX-1
inhibitor, aspirin. Furthermore, progesterone and 17
-estradiol
suppressed the IL-1
-augmented COX-2 production but not the
constitutive production of COX-1 in rabbit uterine cervical
fibroblasts. These results suggest that progesterone and
17
-estradiol prevent the initiation of labor by inhibiting
PGE2 production after the suppression of COX-2 production
during pregnancy in the rabbit.
pregnancy; uterine contraction; parturition; labor; prostaglandin E2; cyclooxygenase-2
| |
INTRODUCTION |
|---|
|
|
|---|
PROSTAGLANDINS (PGs)
play an important role in the regulation of uterine function such as
parturition during the reproductive process. An increased level
of prostanoids such as PGE2 and PGF2
causes
the myometrial contractility that initiates labor at term (26,
27). Suppression of PG levels results in delay of labor in
humans and animals (22, 34, 40). The production of PGs is
regulated by cyclooxygenase (COX)/prostaglandin endoperoxide H synthase
(PGHS), and two types of the enzyme, COX-1/PGHS-1 and COX-2/PGHS-2,
have been characterized in mammalian cells (8, 13). COX-1 is constitutively expressed in most tissues
and cultured cells, and COX-2 is an inducible enzyme in response to
inflammatory cytokines and growth factors (4, 20, 31, 35).
Therefore, COX-1 and COX-2 may participate in parturition by increasing
prostanoid metabolism (36, 39, 42). A recent study with
PGF receptor-deficient mice by Tsuboi et al. (37)
indicates that COX-2 is closely associated with the occurrence of
parturition but that COX-1 is induced much earlier and kept at a high
level in uterine tissue until the initiation of parturition.
Uterine cervical ripening is a typical event with dramatic connective
tissue remodeling (17, 24) and is regulated by various endogenous factors such as inflammatory cytokines, sex hormones, and
proteases. Our laboratory demonstrated that, in rabbit uterine cervix,
progesterone and 17
-estradiol suppress the production of matrix
metalloproteinases (MMPs), which play an important role in the
degradation of extracellular matrix at the onset of parturition (14, 32). Our laboratory also demonstrated that an
augmented production of interleukin (IL)-1 and IL-8 is observed in
pregnant rabbit uterine cervices (15, 38) and that the
production of IL-8 is transcriptionally suppressed by progesterone in
rabbit uterine cervical fibroblasts (16). Therefore, it is
proposed that the sex hormone-mediated suppression of MMP and cytokine production is a key mechanism for maintaining the uterus during pregnancy in rabbit. Moreover, previous studies indicate that PGE2 produced during gestation is involved in cervical
ripening in sheep and ovine (25, 28), but the hormonal
regulation of PG biosynthesis in uterus is controversial. It has been
reported that estradiol decreases both PGF2
and
PGE2 by suppressing COX-2 mRNA expression, whereas
progesterone increases PGF2
secretion in bovine
endometrial cells (41). In addition, in bovine myometrium,
progesterone but not 17
-estradiol suppresses COX-2 mRNA expression
(6). Furthermore, Kim et al. (21) reported that progesterone suppresses COX-1 but not COX-2 expression in baboon endometrium.
In the present study, we demonstrated that IL-1
increased the
biosynthesis of PGE2 and that the augmented
PGE2 level was suppressed by both progesterone and
17
-estradiol in rabbit uterine cervical fibroblasts. Furthermore,
these hormones suppressed the production of COX-2, but not COX-1, in
the IL-1
-treated uterine cervical fibroblasts.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture and treatment.
Uterine cervical fibroblasts were prepared from Nippon White rabbits at
a gestational age of 23 days and maintained in culture in MEM (Life
Technologies, Grand Island, NY) supplemented with 10% fetal bovine
serum (BioWhittaker, Walkersville, MD), as described previously
(14, 15, 16, 32, 38). In all experiments, cells up
to the fourth passage were used. After achieving confluence, the cells were washed once with MEM supplemented with 0.2% lactalbumin hydrolysate (Sigma Chemical, St. Louis, MO) and then treated with progesterone, 17
-estradiol, indomethacin, aspirin (Sigma Chemical), and NS-398 (Calbiochem-Novabiochem, La Jolla, CA) in the presence or
absence of recombinant human IL-1
(2 × 107 U/mg)
(a generous gift from Dainippon Pharmaceutical, Osaka, Japan) in the
same medium for 24 h. The harvested culture media were stored at
20°C until use.
PGE2 assay. PGE2 contents in the culture media were measured by radioimmunoassay as described previously (33). An aliquot (50 µl) of the harvested culture medium was incubated with [3H]PGE2 (DuPont NEN, Boston, MA) and PGE2 antibody (PerSeptive Diagnostics, Cambridge, MA) in a total volume of 160 µl for 18 h at 4°C, and then 500 µl of 0.025% dextran-25% charcoal-0.9% NaCl were added to remove the unbound [3H]PGE2. After incubation for 15 min at 4°C, the reaction mixture was subjected to centrifugation and the radioactivity in the resultant supernatant was counted. The amount of PGE2 was calculated from a standard curve performed concomitantly using authentic PGE2.
COX activity measurement.
COX activity was determined by the method of Pentland and
Needleman (29). After the uterine cervical fibroblasts
were treated with IL-1
and/or steroid hormones, the cells were
washed once with 0.2% lactalbumin hydrolysate-MEM and then incubated
in the same medium containing 30 µM arachidonic acid (Sigma Chemical) for 5 min. The amounts of PGE2 converted from arachidonic
acid in the culture medium were measured by radioimmunoassay.
Western blot analysis for COX-1 and COX-2.
To monitor the production of COX-1 and COX-2, the cells were pretreated
with progesterone and 17
-estradiol for 24 h and then treated
with the hormones in the presence or absence of IL-1
for 24 h.
The cells were washed once with Ca2+- and
Mg2+-free PBS and then lysed with 50 mM Tris · HCl
(pH 7.5)-2% SDS-10% glycerol-5% 2-mercaptoethanol. The lysate was
boiled for 12 min and then mixed with trichloroacetic acid at the final
concentration of 3.33%. After centrifugation, the
precipitated proteins were separated by SDS-polyacrylamide gel
electrophoresis using 10% acrylamide gel and electrotransferred onto a
nitrocellulose membrane. The membrane was reacted with monoclonal
anti-murine COX-1 or anti-murine COX-2 antibody (Cayman Chemical, Ann
Arbor, MI), which was then complexed with horseradish
peroxidase-conjugated rabbit anti-mouse IgG (Sigma Chemical).
Immunoreactive COX-1 and COX-2 were visualized with enhanced
chemiluminescence-Western blotting detection reagents (Amersham Life
Science, Tokyo, Japan) using Image Analyzer LAS-1000 plus (Fuji Photo
Film, Tokyo, Japan).
Statistical analysis. Data were analyzed by Student's t-test; P < 0.05 was considered to be statistically significant.
| |
RESULTS |
|---|
|
|
|---|
IL-1
increases PGE2 level in rabbit uterine cervical
fibroblasts.
When rabbit uterine cervical fibroblasts were treated with IL-1
, the
level of PGE2 increased in a dose-dependent manner (Fig. 1A). The maximal effect was
observed at 0.5 ng/ml of IL-1
(column 3). The
augmentation of PGE2 level by IL-1
was also time
dependent; a twofold increase was observed within 2 h, and then
the induction reached a plateau for 6-10 h (Fig. 1B).
In addition, IL-1
-augmented PGE2 level was completely
diminished by a broad COX inhibitor, indomethacin (10 µM), and by a
COX-2-specific inhibitor, NS-398 (1 µM), but not by aspirin (1 µM),
which is a well-known COX-1 inhibitor (Fig.
2). We furthermore confirmed that the
conversion of exogenous arachidonic acid to PGE2 was
enhanced by IL-1
and that the COX activity was no longer detected in
rabbit uterine cervical fibroblasts treated with NS-398 and
indomethacin but was detected in those treated with aspirin (data not
shown). Thus these results suggest that IL-1
-augmented
PGE2 level is dependent on COX-2 activity in rabbit uterine
cervical fibroblasts.
|
|
Progesterone and 17
-estradiol suppress the level of
PGE2 and COX-2 activity in rabbit uterine cervical
fibroblasts.
As shown in Fig. 3, progesterone and
17
-estradiol decreased the IL-1
-augmented PGE2 level
in rabbit uterine cervical fibroblasts and the suppression was found to
be significant at 0.01 µM (columns 3 and 6). A
slight decrease in the basal level of PGE2 by both hormones
was also observed at the relatively high concentration (1 µM)
(columns 9 and 10). Furthermore, the
IL-1
-augmented COX-2 activity (1.3-fold) was similarly inhibited by
progesterone and 17
-estradiol in rabbit uterine cervical fibroblasts
(Table 1), suggesting that the hormonal
suppression of PGE2 production is due to the inhibition of
COX-2 activity by progesterone and 17
-estradiol.
|
|
Progesterone and 17
-estradiol suppress the production of COX-2,
but not COX-1, in rabbit uterine cervical fibroblasts.
To investigate whether progesterone and 17
-estradiol altered the
production of COX isoforms, Western blot analysis was performed. As
shown in Fig. 4A, the
production of COX-1 was constitutively but slightly detected in rabbit
uterine cervical fibroblasts and not influenced by IL-1
treatment.
In contrast, the production of COX-2 was obviously augmented in the
IL-1
-treated cervical fibroblasts, although there was no signal
corresponding to COX-2 in the untreated cells (Fig. 4B).
Both progesterone and 17
-estradiol were found to suppress the
IL-1
-induced COX-2 production but not the constitutive expression of
COX-1 (Fig. 4, A and B), suggesting that
progesterone and 17
-estradiol suppress the production of PGE2 accompanying the specific inhibition of COX-2 in
rabbit uterine cervical fibroblasts.
|
| |
DISCUSSION |
|---|
|
|
|---|
The level of prostanoids such as PGE2,
PGF2
, and thromboxane A2 in plasma and
amniotic fluid is known to increase before the onset of labor and is
further augmented throughout labor (1-4). MacDonald
et al. (23) reported that arachidonic acid initiates labor
and accelerates delivery near term, suggesting that the increase of
prostanoid production is closely involved in the acceleration of
parturition. In the present study, we demonstrated that progesterone and 17
-estradiol decreased the level of PGE2 in rabbit
uterine cervical fibroblasts (Fig. 3). The plasma level of progesterone and 17
-estradiol in rabbit increases from early to late gestation, and then the decrease of the hormone levels correlates with the initiation of delivery at term (2, 12). Therefore, we
suggest that progesterone and 17
-estradiol are endogenous
suppressors of prostanoid metabolism in uterine cervix during gestation.
The production of PGs is regulated by COXs, and two isotypes, COX-1 and
COX-2, have been characterized (8, 13). COX-2 is an
inducible enzyme produced in response to inflammatory stimuli, whereas
COX-1 is constitutively expressed in various cell lines and tissues
(4, 20, 31, 35). COX-2 mRNA and its protein expression in
amnion epithelium and decidua are augmented by IL-1
, tumor necrosis
factor-
(TNF-
) and epidermal growth factor (10, 19,
30). We demonstrated that IL-1
increased PGE2
level in rabbit uterine cervical fibroblasts (Fig. 1), which was
disrupted in the presence of NS-398 and indomethacin but not aspirin
(Fig. 2). Furthermore, the IL-1
-induced COX activity was completely inhibited by adding NS-398 and indomethacin (data not shown). In
addition, our results showed that IL-1
augmented the production of
COX-2, but not COX-1, in the cervical fibroblasts (Fig. 4). Therefore,
we suggest that IL-1
induces COX-2 activity along with augmenting
COX-2 production in rabbit uterine cervical fibroblasts. Furthermore,
it has been reported that inflammatory cytokines such as IL-1 and
TNF-
are highly detectable during pregnancy (3, 5, 16).
With these findings taken together, we speculate that COX-2 is an
enzyme that has a substantial role in the control of uterine
contraction and that the uterine cervix may be one of the sources
producing prostanoids to cause the onset of labor at term.
Goodwin et al. (9) reported that IL-4 transcriptionally
suppresses the expression of COX-2 in human placental trophoblast cells. In addition, recent reports have shown that IL-10 and IL-13 inhibit the biosynthesis of PGE2 in human amnion, chorion,
and decidual cells by a mechanism whereby the production of COX-2 may
be suppressed (7, 18). However, the involvement of these cytokines in parturition remains controversial. On the other hand, it
has been reported that progesterone and 17
-estradiol are
significantly detected during gestation (2, 12). In the
present study, we demonstrated that progesterone and 17
-estradiol
diminished the production of COX-2 and subsequently decreased the level
of PGE2 in rabbit uterine cervical fibroblasts (Figs. 3 and
4). Our laboratory's previous studies also indicate that progesterone and 17
-estradiol inhibit the gene expression and production of MMPs
and IL-8 in rabbit uterine cervical fibroblasts (14, 16, 32). Taken together, these results suggest that the suppression of COX-2 production by both hormones may be due to that of its gene
expression in rabbit uterine cervical fibroblasts. Moreover, we propose
that progesterone and 17
-estradiol are crucial hormones for
functionally maintaining the uterus during pregnancy in rabbit.
Recently, several reports indicate discrepancies in the hormonal
regulation of PG production. Hedin and Eriksson (11)
reported that progesterone inhibits PG synthesis by suppressing COX-2
expression in rat follicles. In contrast, Badawi and Archer
(1) reported that both COX-1 and COX-2 expression are
augmented by the administration of progesterone and estradiol in
ovariectomized rat. On the other hand, although estradiol has been
shown to decrease the level of COX-2 mRNA in bovine endometrial cells
(41), its gene expression is suppressed by progesterone
but not 17
-estradiol in bovine myometrium (6). Taken
together with our finding that rabbit COX-2 expression is suppressed by
both progesterone and 17
-estradiol, it is suggested that hormonal
regulation of COX expression in reproductive tracts may differ
depending on animal species and the reproductive condition, such as
menstrual cycle or pregnancy.
In conclusion, we demonstrated that progesterone and 17
-estradiol
repressed prostanoid metabolism by decreasing the production of COX-2
in rabbit uterine cervical fibroblasts. These results suggest that
progesterone and 17
-estradiol substantially participate in
preventing the uterine contraction initiated by PGs during gestation.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported in part by Program for Promotion of Basic Research Activities for Innovative Biosciences (BRAIN).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: T. Sato, Dept. of Biochemistry, Tokyo Univ. of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji, Tokyo 192-0392, Japan (E-mail: satotak{at}ps.toyaku.ac.jp).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 26 July 2000; accepted in final form 16 October 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Badawi, AF,
and
Archer MC.
Effect of hormonal status on the expression of the cyclooxygenase 1 and 2 genes and prostaglandin synthesis in rat mammary glands.
Prostaglandins Other Lipid Mediat
56:
167-181,
1998[ISI][Medline].
2.
Challis, JRG,
Davies IJ,
and
Ryan KJ.
Concentrations of progesterone, estrone and estradiol-17
in the plasma of pregnant rabbits.
Endocrinology
93:
971-976,
1973[ISI][Medline].
3.
Chen, HL,
Yang YP,
Hu XL,
Yelavarthi KK,
Fishback JL,
and
Hunt JS.
Tumor necrosis factor
mRNA and protein are present in human placental and uterine cells at early and late stages of gestation.
Am J Pathol
139:
327-335,
1991[Abstract].
4.
Crofford, LJ,
Wilder RL,
Ristimäki AP,
Sano H,
Remmers EF,
Epps HR,
and
Hla T.
Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissue: effects of interleukin-1
, phorbol ester, and corticosteroids.
J Clin Invest
93:
1095-1101,
1994.
5.
De, M,
Sanford TR,
and
Wood GW.
Expression of interleukin 1, interleukin 6 and tumor necrosis factor
in mouse uterus during the periimplantation period of pregnancy.
J Reprod Fertil
97:
83-89,
1993[Abstract].
6.
Doualla Bell, F,
Guay JM,
Bourgoin S,
and
Fortier MA.
Prostaglandin G/H synthase (PGHS)-2 expression in bovine myometrium: influence of steroid hormones and PGHS inhibitors.
Biol Reprod
59:
1433-1438,
1998
7.
Dudley, DJ,
Edwin SS,
Dangerfield A,
and
Mitchell MD.
Effects of interleukin 10 (IL-10) on prostaglandin E2 production by fetal amnion and chorion cells (Abstract).
J Soc Gynecol Investig
3:
320A,
1996.
8.
Funk, CD,
Funk LB,
Kennedy ME,
Pong AS,
and
Fitzgerald GA.
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment.
FASEB J
5:
2304-2312,
1991[Abstract].
9.
Goodwin, VJ,
Mitchel MD,
and
Keelan JA.
The effect of anti-inflammatory cytokines on prostaglandin and cytokine production by human placental trophoblast cells.
Am J Reprod Immunol
40:
319-325,
1998.
10.
Hansen, WR,
Sato T,
and
Mitchell MD.
Tumor necrosis factor-
stimulates increased expression of prostaglandin endoperoxide H synthase type 2 mRNA in amnion-derived WISH cells.
J Mol Endocrinol
20:
221-231,
1998[Abstract].
11.
Hedin, L,
and
Eriksson A.
Prostaglandin synthesis is suppressed by progesterone in rat preovulatory follicles in vitro.
Prostaglandins
53:
91-106,
1997[ISI][Medline].
12.
Hilliard, J,
Scaramuzzi RJ,
Penardi R,
and
Sawyer CH.
Progesterone, estradiol and testosterone levels in ovarian venous blood of pregnant rabbits.
Endocrinology
93:
1235-1238,
1973[ISI][Medline].
13.
Hla, T,
and
Neilson K.
Human cyclooxygenase 2 cDNA.
Proc Natl Acad Sci USA
89:
7384-7388,
1992
14.
Imada, K,
Ito A,
Sato T,
Namiki M,
Nagase H,
and
Mori Y.
Hormonal regulation of matrix metalloproteinase 9/gelatinase B gene expression in rabbit uterine cervical fibroblasts.
Biol Reprod
56:
575-580,
1997[Abstract].
15.
Ito, A,
Hiro D,
Ojima Y,
and
Mori Y.
Spontaneous production of interleukin-1-like factors from pregnant rabbit uterine cervix.
Am J Obstet Gynecol
159:
261-265,
1988[ISI][Medline].
16.
Ito, A,
Imada K,
Sato T,
Kubo T,
Matsushima K,
and
Mori Y.
Suppression of interleukin 8 production by progesterone in rabbit uterine cervix.
Biochem J
301:
183-186,
1994.
17.
Ito, A,
Kitamura H,
Mori Y,
and
Hirakawa S.
The change in solubility of type I collagen in human uterine cervix in pregnancy at term.
Biochem Med
21:
262-270,
1979[ISI][Medline].
18.
Keelan, JA,
Sato T,
and
Mitchell MD.
Comparative effects of interleukin (IL)-13 and IL-4 on production of cytokines and prostaglandins by amnion-derived WISH cells.
Am J Reprod Immunol
40:
332-338,
1998.
19.
Kennard, EA,
Zimmerman PD,
Friedman CI,
and
Kniss DA.
IL-1 beta induces cyclooxygenase-2 in cultured human decidual cells.
Am J Reprod Immunol
34:
65-71,
1995.
20.
Kester, M,
Coroneos E,
Thomas PJ,
and
Dunn MJ.
Endothelin stimulates prostaglandin endoperoxide synthase-2 mRNA expression and protein synthesis through a tyrosine kinase-signaling pathway in rat mesangial cells.
J Biol Chem
269:
22574-22580,
1994
21.
Kim, JJ,
Wang J,
Bambra C,
Das SK,
Dey SK,
and
Fazleabas AT.
Expression of cyclooxygenase-1 and -2 in the baboon endometrium during the menstrual cycle and pregnancy.
Endocrinology
140:
2672-2678,
1999
22.
Lewis, RB,
and
Schulman JD.
Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labor.
Lancet
2:
1159-1161,
1973[ISI][Medline].
23.
MacDonald, PC,
Schultz FM,
Duenhoelter JH,
Gant NF,
Jimenez JM,
Pritchard JA,
Porter JC,
and
Johnston JM.
Initiation of human parturition. I. Mechanism of action of arachidonic acid.
Obstet Gynecol
44:
629-636,
1974
24.
Minamoto, T,
Arai K,
Hirakawa S,
and
Nagai Y.
Immunohistochemical studies on collagen types in the uterine cervix in pregnant and nonpregnant states.
Am J Obstet Gynecol
156:
138-144,
1987[ISI][Medline].
25.
Mitchell, M.
Pathways of arachidonic acid metabolism with specific application to the fetus and mother.
Semin Perinatol
10:
242-254,
1986[ISI][Medline].
26.
Mitchell, MD,
Romero RJ,
Edwin SS,
and
Trautman MS.
Prostaglandins and parturition.
Reprod Fertil Dev
7:
623-632,
1995[Medline].
27.
Novy, MJ,
and
Liggins GC.
Role of prostaglandins, prostacyclin and thromboxanes in the physiological control of the uterus and in parturition.
Semin Perinatol
4:
45-66,
1980[ISI][Medline].
28.
Owiny, J,
and
Fitzpatrick R.
Effect of intravaginal application of prostaglandin E2 gel on the mechanical properties of the ovine cervix uteri at term.
Am J Obstet Gynecol
163:
657-660,
1990[ISI][Medline].
29.
Pentland, AP,
and
Needleman P.
Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis.
J Clin Invest
77:
246-251,
1986.
30.
Perkins, DJ,
and
Kniss DA.
Rapid and transient induction of cyclooxygenase 2 by epidermal growth factor in human amnion-derived WISH cells.
Biochem J
321:
677-681,
1997.
31.
Ristimäki, A,
Garfinkel S,
Wessendorf J,
Maciag T,
and
Hla T.
Induction of cyclooxygenase-2 by interleukin-1
; evidence for post-transcriptional regulation.
J Biol Chem
269:
11769-11775,
1994
32.
Sato, T,
Ito A,
Mori Y,
Yamashita K,
Hayakawa T,
and
Nagase H.
Hormonal regulation of collagenolysis in uterine cervical fibroblasts. Modulation of synthesis of procollagenase, prostromelysin and tissue inhibitor of metalloproteinases (TIMP) by progesterone and oestradiol-17
.
Biochem J
275:
645-650,
1991.
33.
Sato, T,
Nakajima H,
Fujio K,
and
Mori Y.
Enhancement of prostaglandin E2 production by epidermal growth factor requires the coordinate activation of cytosolic phospholipase A2 and cyclooxygenase 2 in human squamous carcinoma A431 cells.
Prostaglandins
53:
355-369,
1997[ISI][Medline].
34.
Sellers, SM,
Mitchell MD,
Anderson AB,
and
Turnbull AC.
The relation between the release of prostaglandins at amniotomy and the subsequent onset of labor.
Br J Obstet Gynaecol
88:
1211-1216,
1981[ISI][Medline].
35.
Stroebel, M,
and
Goppelt-Struebe M.
Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells.
J Biol Chem
269:
22952-22957,
1994
36.
Teixeira, FJ,
Zakar T,
Hirst JJ,
Guo F,
Sadowsky DW,
Machin G,
Demianczuk N,
Resch B,
and
Olson DM.
Prostaglandin endoperoxide-H synthase (PGHS) activity and immunoreactive PGHS-1 and PGHS-2 levels in human amnion throughout gestation, at term, and during labor.
J Clin Endocrinol Metab
78:
1396-1402,
1994[Abstract].
37.
Tsuboi, K,
Sugimoto Y,
Iwane A,
Yamamoto K,
Yamamoto S,
and
Ichikawa A.
Uterine expression of prostaglandin H2 synthase in late pregnancy and during parturition in prostaglandin F receptor-deficient mice.
Endocrinology
141:
315-324,
2000
38.
Uchiyama, T,
Ito A,
Ikesue A,
Nakagawa H,
and
Mori Y.
Chemotactic factor in the pregnant rabbit uterine cervix.
Am J Obstet Gynecol
167:
1417-1422,
1992[ISI][Medline].
39.
Wimsatt, J,
Nathanielsz PW,
and
Sirois J.
Induction of prostaglandin endoperoxide synthase isoform-2 in ovine cotyledonary tissue during late gestation.
Endocrinology
133:
1068-1073,
1993[Abstract].
40.
Wiqvist, N,
Lindblom B,
Wikland M,
and
Wilhelmsson L.
Prostaglandins and uterine contractility.
Acta Obstet Gynecol Scand
113:
23-29,
1983.
41.
Xiao, CW,
Liu JM,
Sirois J,
and
Goff AK.
Regulation of cyclooxygenase-2 and prostaglandin F synthase gene expression by steroid hormones and interferon-
in bovine endometrial cells.
Endocrinology
139:
2293-2299,
1998
42.
Zuo, J,
Lei ZM,
Rao CV,
Pietrantoni M,
and
Cook VD.
Differential cyclooxygenase-1 and -2 gene expression in human myometria from preterm and term deliveries.
J Clin Endocrinol Metab
79:
894-899,
1994[Abstract].
This article has been cited by other articles:
![]() |
C. M. Kershaw, R. J. Scaramuzzi, M. R. McGowan, C. P.D. Wheeler-Jones, and M. Khalid The Expression of Prostaglandin Endoperoxide Synthase 2 Messenger RNA and the Proportion of Smooth Muscle and Collagen in the Sheep Cervix During the Estrous Cycle Biol Reprod, January 1, 2007; 76(1): 124 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ospina, H. N. Brevig, D. N. Krause, and S. P. Duckles Estrogen suppresses IL-1{beta}-mediated induction of COX-2 pathway in rat cerebral blood vessels Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H2010 - H2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Schmitz, M.J. Leroy, E. Dallot, M. Breuiller-Fouche, F. Ferre, and D. Cabrol Interleukin-1{beta} induces glycosaminoglycan synthesis via the prostaglandin E2 pathway in cultured human cervical fibroblasts Mol. Hum. Reprod., January 1, 2003; 9(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Armstrong, Y. Zhang, K. G. Stewart, and S. T. Davidge Estrogen replacement reduces PGHS-2-dependent vasoconstriction in the aged rat Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H893 - H898. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |